FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Wolfe Clinton James
2. Issuer Name and Ticker or Trading Symbol

IMS Health Holdings, Inc. [ IMS ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
VP, Human Resources
(Last)          (First)          (Middle)

C/O IMS HEALTH HOLDINGS, INC., 83 WOOSTER HEIGHTS ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

10/3/2016
(Street)

DANBURY, CT 06810
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/3/2016     A    5981   A   (1) (2) 5981   D  
 
Common Stock   10/3/2016     A    7463   A   (3) 13444   D  
 
Common Stock   10/3/2016     D    13444   D   (4) 0   D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   $10.00   10/3/2016     D         16000    2/26/2012   3/15/2020   Common Stock   16000     (5) 0   D  
 
Employee Stock Option (right to buy)   $5.80   10/3/2016     D         6000    2/26/2013   3/15/2020   Common Stock   6000     (6) 0   D  
 
Employee Stock Option (right to buy)   $3.20   10/3/2016     D         8000    2/26/2015   3/15/2020   Common Stock   8000     (7) 0   D  
 
Employee Stock Option (right to buy)   $10.90   10/3/2016     D         6000    2/13/2016   2/13/2023   Common Stock   6000     (8) 0   D  
 
Employee Stock Option (right to buy)   $10.90   10/3/2016     D         2400      (9) 2/13/2023   Common Stock   2400     (10) 0   D  
 
Employee Stock Option (right to buy)   $10.90   10/3/2016     D         1600      (9) 2/13/2023   Common Stock   1600   (11)   (12) 0   D  
 
Stock Appreciation Right   $25.02   10/3/2016     D         3371    2/10/2016   2/10/2025   Common Stock   3371     (13) 0   D  
 
Stock Appreciation Right   $25.02   10/3/2016     D         10113      (14) 2/10/2025   Common Stock   10113     (15) 0   D  
 
Stock Appreciation Right   $23.00   10/3/2016     D         16613      (16) 2/2/2026   Common Stock   16613     (17) 0   D  
 

Explanation of Responses:
( 1)  On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
( 2)  On February 10, 2015 the reporting person was granted 5,018 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 5,981 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 2,296 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017.
( 3)  On February 2, 2016, the reporting person was granted 5,420 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 7,463 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 2,865 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018.
( 4)  Disposed of pursuant to merger agreement in exchange for 5,162 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
( 5)  This option was assumed by Quintiles in the merger and replaced with an option to purchase 6,144 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
( 6)  This option was assumed by Quintiles in the merger and replaced with an option to purchase 2,304 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
( 7)  This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,072 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.
( 8)  This option was assumed by Quintiles in the merger and replaced with an option to purchase 2,304 shares of Quintiles IMS Holdings, Inc. common stock at a price of $28.39 per share.
( 9)  This option vests in two annual installments beginning on February 13, 2017.
( 10)  This option was assumed by Quintiles in the merger and replaced with an option to purchase 921 shares of Quintiles IMS Holdings, Inc. common stock at a price of $28.39 per share.
( 11)  On February 13, 2013, the reporting person was granted a performance-based option to purchase 4,000 shares of issuer common stock. This option vests in five equal annual installments beginning February 13, 2014, subject to achievement of certain performance criteria for each of the fiscal years ending December 31, 2013, 2014, 2015, 2016, and 2017. In connection with the merger, the performance criteria was achieved resulting in 1,600 options earned. The performance-based option was assumed by Quintiles in the merger and replaced with a time-based option.
( 12)  This option was assumed by Quintiles in the merger and replaced with an option to purchase 614 shares of Quintiles IMS Holdings, Inc. common stock at a price of $28.39 per share.
( 13)  This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 1,294 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
( 14)  This stock appreciation right vests in three annual installments beginning on February 10, 2017.
( 15)  This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 3,883 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
( 16)  This stock appreciation right vests in four annual installments beginning on February 2, 2017.
( 17)  This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 6,379 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Wolfe Clinton James
C/O IMS HEALTH HOLDINGS, INC.
83 WOOSTER HEIGHTS ROAD
DANBURY, CT 06810


VP, Human Resources

Signatures
/s/ Harvey A. Ashman, Attorney-in-Fact 10/3/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more IMS HEALTH HOLDINGS, INC. Charts.
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more IMS HEALTH HOLDINGS, INC. Charts.